FindTrial
Sign In

Study on the Effectiveness of TOF-PET/CT System in Improving the Quantitative Value of Tumors

Study on the Effectiveness of TOF-PET/CT System in Improving the Quantitative Value of Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-jRCT1022230020
Enrollment
24
Registered
2023-08-24
Start date
2023-08-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumors of the lung Tumors of the digestive tract Tumors of the lung, Tumors of the digestive tract

Interventions

None listed

Sponsors

Watanabe Yuya
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent a PET/CT scan between December 1, 2022 and June 30, 2023. Patients diagnosed by a physician as having tumors of the upper lobe of the lung, lower lobe of the lung, or gastrointestinal tract.

Exclusion criteria

Exclusion criteria: Patients with a blood glucose level of 150 mg/dL or higher Patients with strong physiological accumulation in the gastrointestinal tract

Design outcomes

Primary

MeasureTime frame
Tumor SUVmax—

Secondary

MeasureTime frame
SUVmean of tumor Tumor size—

Contacts

Public ContactYuya Watanabe

Hirosaki University

h21gg704@hirosaki-u.ac.jp+81-172-33-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026